| Financial Year |
March 31 2023 |
| Monetary Funds |
8,104,135,915.00 |
| Held-for-trading Financial Assets |
1,013,498,180.72 |
| Notes Receivable |
1,462,292,634.19 |
| Accounts Receivable |
5,980,642,877.07 |
| Advances to Suppliers |
715,207,451.14 |
| Other Receivables |
75,542,157.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,216,425,482.47 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
504,546,192.51 |
| Total Current Assets |
26,275,347,563.19 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,153,488,416.17 |
| Investment Properties |
343,398,960.97 |
| Fixed Assetes |
3,047,705,067.80 |
| Under-construction Projects |
1,957,106,142.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
708,804,095.99 |
| R&D expenses |
-- |
| Goodwill |
1,974,703,676.32 |
| Long-Term Deferred and Prepaid Expenses |
155,608,158.72 |
| Deferred Income Tax Assets |
753,543,868.60 |
| Other Non-Current Assets |
687,426,867.82 |
| Sub-Total of Non-Current Assets |
13,839,739,268.88 |
| Total Assets |
40,115,086,832.07 |
| Short-Term Loans |
1,422,849,565.64 |
| Trading Financial liabilities |
6,635,615.33 |
| Notes Payable |
5,210,729,723.54 |
| Accounts Payable |
4,267,222,015.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
988,822,173.36 |
| Taxes Payable |
191,620,039.09 |
| Interest Payable |
-- |
| Dividend Payable |
55,637,330.81 |
| Other payables |
735,204,116.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
646,841,524.13 |
| Other Current Liabilities |
645,364,528.81 |
| Sub-Total of Current Liabilities |
15,236,956,018.96 |
| Long-term Loans |
2,246,366,282.75 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
230,444,012.11 |
| Deferred Income Tax Liabilities |
190,792,427.33 |
| Other Non-Current Liabilities |
536,504,257.87 |
| Sub-Total of Non-Current Liabilities |
3,590,487,626.44 |
| Total Liabilities |
18,827,443,645.40 |
| Paid-In Capital(Or Share Stock) |
2,660,334,876.00 |
| Capital Surplus |
5,059,861,330.74 |
| Surplus Reserve |
1,071,729,967.74 |
| LESS:Treasury Stock |
205,604,128.48 |
| Undistributed Profits |
12,249,288,308.59 |
| Minority Stockholder's Interest |
441,692,805.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
20,845,950,380.75 |
| Owner's Equity（Stockholder's Equity） |
21,287,643,186.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
40,115,086,832.07 |
